Editas Medicine Inc (EDIT): Editas Medicine Announces Pricing of Ini...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	58
Posts	1635
Boards Moderated	0
Alias Born	11/14/2012

protagonist12

Re: None

Tuesday, 02/02/2016 11:51:38 PM

Tuesday, February 02, 2016 11:51:38 PM

Editas Medicine Announces Pricing of Initial Public Offering

Editas Medicine, Inc., a leading genome editing company, today announced the pricing of its initial public offering of 5,900,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. All of the shares are being offered by Editas Medicine. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 885,000 shares of common stock from Editas Medicine at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The company’s common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading on Wednesday, February 3, 2016 under the ticker symbol “EDIT.”

Morgan Stanley and J.P. Morgan are acting as joint book-running managers for the offering. Cowen and Company is acting as lead manager, and JMP Securities is acting as co-manager for the offering.